BioUtah News
-
PolarityTE Reports Third Quarter Financial Results and Provides Business Update
PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended…
-
Renalytix Convenes Expert Panel at VA Healthcare Summit
Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease
-
St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York
Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first…
-
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom
Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations
-
New report shows more than 260 medicines in development to fight neurodegenerative diseases
PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases
-
Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial
Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying…
-
Wilson Sonsini to open Salt Lake City office with trio of lawyers
Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S.…
-
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on…
-
FDA Clears 12 New XO Cross Microcatheters
12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.
-
St. George could become Utah’s next tech hub
Utah has now become a VC darling with a maturing ecosystem complete with angels, seed-stage, growth stage, and…
-
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
